Immortalized B lymphocytes produce B-cell growth factor

Area of Science:

• Immunology
• Virology
• Oncology

Background:

• B lymphocyte activation, expansion, and differentiation are cytokine-dependent processes.
• Epstein-Barr virus (EBV) is a unique B-cell mitogen that bypasses accessory cell requirements.
• EBV-transformed lymphocytes exhibit continuous proliferation, independent of external cytokines, and share traits with preneoplastic states.

Purpose of the Study:

• To investigate the mechanism by which EBV-transformed B lymphoblasts sustain their growth.
• To identify soluble factors produced by EBV-transformed B lymphoblasts.
• To explore the role of these factors in malignant evolution of EBV-associated lymphomas.

Main Methods:

• Transformation of B lymphocytes with Epstein-Barr virus (EBV).
• Analysis of soluble factors released by EBV-transformed B lymphoblasts.
• Assessment of the growth-sustaining activity of these factors on the transformed cells.

Main Results:

• EBV-transformed B lymphoblasts release a soluble factor.
• This factor mimics the B-cell stimulatory products of mitogen-conditioned T lymphocytes.
• The virally-transformed cells utilize this autocrine growth factor to sustain their continuous proliferation.

Conclusions:

• Ectopic production of a growth factor by EBV-transformed B lymphoblasts is a critical event.
• This autocrine mechanism contributes to the uncontrolled growth observed in EBV-associated lymphomas.
• The findings suggest a potential pathway for malignant transformation in human lymphomas harboring EBV.